Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 314–314 | Cite as

Nivolumab/sunitinib

Acute fulminant hepatitis: case report
Case report
  • 14 Downloads

Reference

  1. Inamori O, et al. Fulminant hepatitis as an immune-related adverse event after nivolumab treatment. Pathology International 69: 434-436, No. 7, Jul 2019. Available from: URL: http://doi.org/10.1111/pin.12812 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations